HO-1 induction improves the type-1 cardiorenal syndrome in mice with impaired angiotensin II-induced lymphocyte activation

Hypertension

Volumn 62, Issue 2, 2013, Pages 310-316

  Monu, Sumit R ^a,c   Pesce, Paola ^a   Sodhi, Komal ^a   Boldrin, Massimo ^a,b   Puri, Nitin ^c   Fedorova, Larisa ^c   Sacerdoti, David ^a   Peterson, Stephen J ^d   Abraham, Nader G ^a   Kappas, Attallah ^e  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c MEDICAL COLLEGE OF OHIO   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Angiotensin II; Heart failure; Heme oxygenase 1; T lymphocytes; Vasoconstriction

Indexed keywords

ANGIOTENSIN II; CREATININE; HEME OXYGENASE 1; MESOPORPHYRIN; PROTOPORPHYRIN COBALT; RENIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIORENAL SYNDROME; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FUNCTION; HEART INFARCTION; KIDNEY FUNCTION; KIDNEY INJURY; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCID MOUSE; T LYMPHOCYTE;

ANGIOTENSIN II; HEART FAILURE; HEME OXYGENASE-1; T-LYMPHOCYTES; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; BODY WEIGHT; CARDIO-RENAL SYNDROME; CREATININE; ECHOCARDIOGRAPHY; ENZYME INDUCTION; HEME OXYGENASE-1; KIDNEY; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, SCID; RENIN;

EID: 84880933169     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.00495     Document Type: Article

References (35)

1. Bongartz LG, Cramer MJ, Braam B. The cardiorenal connection. Hypertension. 2004;43:e14.
2. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J. 2005;26:11-17.
3. Badzyńska B, Sadowski J. Moderate intrarenal vasoconstriction after high pressor doses of norepinephrine in the rat: comparison with effects of angiotensin II. Kidney Blood Press Res. 2011;34:307-310.
4. Sacerdoti D, Bolognesi M, Merkel C, Angeli P, Gatta A. Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography. Hepatology. 1993;17:219-224.
5. De Miguel C, Das S, Lund H, Mattson DL. T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol. 2010;298:R1136-R1142.
6. Zablocki D, Sadoshima J. Angiotensin II and oxidative stress in the failing heart. Antioxid Redox Signal. 2012. In Press.
7. Abraham NG, Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med. 2005;39:1-25.
8. Marvar PJ, Thabet SR, Guzik TJ, Lob HE, McCann LA, Weyand C, Gordon FJ, Harrison DG. Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res. 2010;107:263-270.
9. Chu PY, Zatta A, Kiriazis H, Chin-Dusting J, Du XJ, Marshall T, Kaye DM. CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excess. Circ Heart Fail. 2011;4:651-658.
10. Kasal DA, Schiffrin EL. Angiotensin II, aldosterone, and anti-inflammatory lymphocytes: interplay and therapeutic opportunities. Int J Hypertens. 2012;2012:829786.
11. Suzuki Y, Ruiz-Ortega M, Gomez-Guerrero C, Tomino Y, Egido J. Angiotensin II, the immune system and renal diseases: another road for RAS? Nephrol Dial Transplant. 2003;18:1423-1426.
12. Abraham NG, Pinto A, Levere RD, Mullane K. Identification of heme oxygenase and cytochrome P-450 in the rabbit heart. J Mol Cell Cardiol. 1987;19:73-81.
13. Abraham NG, Kappas A. Mechanism of heme-heme oxygenase system impairment of endothelium contraction in the spontaneously hypertensive rat. Hypertension. 2011;58:772-773.
14. Perrella MA, Yet SF. Role of heme oxygenase-1 in cardiovascular function. Curr Pharm Des. 2003;9:2479-2487.
15. Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, Ith B, Melo LG, Zhang L, Ingwall JS, Dzau VJ, Lee ME, Perrella MA. Cardiacspecific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res. 2001;89:168-173.
16. Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L, Wiesel P, Christou H, Kourembanas S, Lee ME. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest. 1999;103:R23-R29.
17. Sodhi K, Puri N, Inoue K, Falck JR, Schwartzman ML, Abraham NG. EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels. Prostaglandins Other Lipid Mediat. 2012;98:133-142.
18. Burgess A, Li M, Vanella L, Kim DH, Rezzani R, Rodella L, Sodhi K, Canestraro M, Martasek P, Peterson SJ, Kappas A, Abraham NG. Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice. Hypertension. 2010;56:1124-1130.
19. Nicolai A, Li M, Kim DH, Peterson SJ, Vanella L, Positano V, Gastaldelli A, Rezzani R, Rodella LF, Drummond G, Kusmic C, L'Abbate A, Kappas A, Abraham NG. Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats. Hypertension. 2009;53:508-515.
20. Wang G, Hamid T, Keith RJ, et al. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation. 2010;121:1912-1925.
21. Cao J, Vecoli C, Neglia D, Tavazzi B, Lazzarino G, Novelli M, Masiello P, Wang YT, Puri N, Paolocci N, L'abbate A, Abraham NG. Cobalt- Protoporphyrin improves heart function by blunting oxidative stress and restoring NO synthase equilibrium in an animal model of experimental diabetes. Front Physiol. 2012;3:160.
22. Bolognesi M, Sacerdoti D, Di Pascoli M, Angeli P, Quarta S, Sticca A, Pontisso P, Merkel C, Gatta A. Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites. Gut. 2005;54:1630-1636.
23. Di Pascoli M, Zampieri F, Quarta S, Sacerdoti D, Merkel C, Gatta A, Bolognesi M. Heme oxygenase regulates renal arterial resistance and sodium excretion in cirrhotic rats. J Hepatol. 2011;54:258-264.
24. Wang CF, Wang ZY, Li JY. Dual protective role of HO-1 in transplanted liver grafts: a review of experimental and clinical studies. World J Gastroenterol. 2011;17:3101-3108.
25. Shen Z, Teng X, Qian X, He M, Hu Y, Ye W, Huang H, Yu Y, Chen Y. Immunoregulation effect by overexpression of heme oxygenase- 1 on cardiac xenotransplantation. Transplant Proc. 2011;43: 1994-1997.
26. Besenzon F, Dedja A, Vadori M, Bosio E, Seveso M, Tognato E, Polito L, Calabrese F, Valente M, Rigotti P, Ancona E, Cozzi E. In vitro and in vivo immunomodulatory effects of cobalt protoporphyrin administered in combination with immunosuppressive drugs. Transpl Immunol. 2010;24:1-8.
27. Fedorova LV, Raju V, El-Okdi N, Shidyak A, Kennedy DJ, Vetteth S, Giovannucci DR, Bagrov AY, Fedorova OV, Shapiro JI, Malhotra D. The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition. Am J Physiol Renal Physiol. 2009;296:F922-F934.
28. Cao J, Sodhi K, Inoue K, Quilley J, Rezzani R, Rodella L, Vanella L, Germinario L, Stec DE, Abraham NG, Kappas A. Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension. Hum Gene Ther. 2011;22: 271-282.
29. Chan EJ, Dellsperger KC. Cardiorenal Syndrome: the clinical cardiologists' perspective. Cardiorenal Med. 2011;1:13-22.
30. Schiffrin EL. T lymphocytes: a role in hypertension? Curr Opin Nephrol Hypertens. 2010;19:181-186.
31. Geiger H, Helmut G. T-cells in angiotensin-II-induced vascular damage. Nephrol Dial Transplant. 2008;23:1107-1108.
32. Ronco C, Cicoira M, McCullough PA. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol. 2012;60:1031-1042.
33. Virzi' GM, de Cal M, Cruz DN, Bolin C, Vescovo G, Ronco C. Type 1 cardiorenal syndrome and its possible pathophysiological mechanisms. G Ital Nefrol. 2012;29:690-698.
34. Guo R, Zhou J, Deng XL, Gao GD, Jiang XY, Lin YX. Angiotensin II increases ROS production in cardiac fibroblasts by inducing p22phox over-expression. Nan Fang Yi Ke Da Xue Xue Bao. 2009;29: 202-204.
35. Coppo M, Boddi M, Bandinelli M, Degl'innocenti D, Ramazzotti M, Marra F, Galastri S, Abbate R, Gensini GF, Poggesi L. Angiotensin II upregulates renin-angiotensin system in human isolated T lymphocytes. Regul Pept. 2008;151:1-6.